CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Current Deferred Revenue came in at $32000.0 in Q4 2021, down 84.54% YoY from $207000.0 in Q4 2020, and down 80.49% on a QoQ basis from $164000.0 in Q1 2021.
CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Current Deferred Revenue data on file, last reported at $32000.0 in Q4 2021.
- Quarterly Current Deferred Revenue fell 84.54% year-over-year to $32000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $32000.0 (down 84.54% YoY) and the FY2021 annual result came in at $32000.0, down 84.54% from the prior year.
- Current Deferred Revenue declined to $32000.0 in Q4 2021, from $164000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.3 million in Q1 2019 to a low of $32000.0 in Q4 2021.
- A 4-year average of $658363.6 and a median of $687000.0 in 2020 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2019 — Current Deferred Revenue retreated 3.88% — and 2021, when it plunged 84.54%.
- Tracing CLGN's Current Deferred Revenue over 4 years: stood at $980000.0 in 2018, then fell by 3.88% to $942000.0 in 2019, then slumped by 78.03% to $207000.0 in 2020, then sank by 84.54% to $32000.0 in 2021.
- The last three Current Deferred Revenue figures came in at $32000.0 (Q4 2021), $164000.0 (Q1 2021), and $207000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 32,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Dec 31, 2020 | 207,000.00 |
| Sep 30, 2020 | 317,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 687,000.00 |
| Dec 31, 2019 | 942,000.00 |
| Sep 30, 2019 | 1.11 Mn |
| Jun 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 980,000.00 |